Skip to main content
. Author manuscript; available in PMC: 2014 Aug 1.
Published in final edited form as: J Vet Pharmacol Ther. 2013 Dec 16;37(4):348–353. doi: 10.1111/jvp.12094

Fig. 2.

Fig. 2

Drug concentration curves for ondansetron administered to healthy cats in a cross-over manner via three routes; i.v., oral, and subcutaneous. Subcutaneous administration sustains statistically significantly higher concentration over time with longer plasma elimination half-life (P < 0.05).